Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug.[1] It has also been evaluated for the treatment of muscle related pain.[2]

It was approved for medical use in the UK in May 2020.[3]

References

  1. ^ Budavari S, ed. (1989). The Merck index an encyclopedia of chemicals, drugs, and biologicals (11th ed., 2nd print. ed.). Rahway, NJ: Merck. p. 7747. ISBN 091191028X.
  2. ^ Überall MA, Essner U, Müller-Schwefe GH (July 2022). "Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain". Current Medical Research and Opinion. 38 (7): 1141–1151. doi:10.1080/03007995.2022.2072089. PMID 35502575.
  3. ^ "Pridinol". SPS - Specialist Pharmacy Service. 10 August 2020. Retrieved 21 August 2020.
  • "Pridinol". Drug Information Portal. U.S. National Library of Medicine.


No tags for this post.